KRAS and ovarian cancer: Using a new in vivo-evolved murine ovarian cancer model termed KMF - denoting gains in genes for Kras, Myc, and FAK – we demonstrate the functional significance of PTK2 (FAK) gains observed in HGSOC tumors.